Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
about
Chemotherapy for children with medulloblastomaPlatinum-induced hearing loss after treatment for childhood cancerNovel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA librariesMir-34a mimics are potential therapeutic agents for p53-mutated and chemo-resistant brain tumour cellsSubsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapyTreatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review.Management of pediatric and adult patients with medulloblastoma.Craniospinal irradiation with concomitant and adjuvant temozolomide--a feasibility assessment of toxicity in patients with glioblastoma with a PNET component.Impact of acute hematological toxicity on treatment interruptions during cranio-spinal irradiation in medulloblastoma: a tertiary care institute experience.Antiangiogenic therapy in the treatment of recurrent medulloblastoma in the adult: case report and review of the literature.Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma.Primary central nervous system primitive neuroectodermal tumors (CNS-PNETs) of the spinal cord in children: four cases from the German HIT database with a critical review of the literature.Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006.c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients.Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology GroupReduced-dose craniospinal radiotherapy followed by high-dose chemotherapy and autologous stem cell rescue for children with newly diagnosed high-risk medulloblastoma or supratentorial primitive neuroectodermal tumorOvercoming multiple drug resistance mechanisms in medulloblastoma.Radiotherapy for medulloblastoma in children: a perspective on current international clinical research efforts.Auditory late effects of childhood cancer therapy: a report from the Children's Oncology GroupKinetics of porphyrin fluorescence accumulation in pediatric brain tumor cells incubated in 5-aminolevulinic acid.Long-term outcomes and role of chemotherapy in adults with newly diagnosed medulloblastoma.Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.Blockade of Inhibitors of Apoptosis Proteins in Combination with Conventional Chemotherapy Leads to Synergistic Antitumor Activity in Medulloblastoma and Cancer Stem-Like Cells.Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis.A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors.Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.Current treatment approaches to early childhood medulloblastoma.Clinical and molecular stratification of disease risk in medulloblastoma.Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.M1 Medulloblastoma: high risk at any ageHigh-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031)Medulloblastoma: from molecular pathology to therapyMedulloblastoma: what is the role of molecular genetics?Chemotherapy for malignant brain tumors of childhood.A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation.Pediatric brain tumors: current treatment strategies and future therapeutic approachesTreatment of posterior fossa tumors in children.
P2860
Q24186770-B5B160F7-135A-4D7A-81CE-995C19795952Q26470526-A926C874-1283-48EB-8FDE-5C65A0EF89CAQ28178383-2740E536-9ACB-430C-8B80-44B004B44414Q28543204-B8386794-0FFB-4B99-9A4F-8CD15979F785Q30389898-927D49E4-433C-424A-9A20-DC7464F89DC9Q30764536-3C15B1F8-08CD-43BC-9568-FD6611F717EBQ30847947-01ADD9E9-A44B-4C57-B6CD-103EE38EC2ACQ33429765-96A5A260-5046-4F06-904A-06793F2D64A5Q33442381-FAFD4E48-F63E-4979-A518-41F42AA96D25Q33580750-D493E78C-F150-46EC-911A-C398E1F6BB77Q33638876-3DD6346D-5702-4944-85B4-B3E717CC2152Q33779142-D234E3D3-43A4-4B1E-82A4-362700D86A66Q33817049-C2861C35-4A1D-45CA-B83A-3F7501AF9FC9Q33821504-9FF5AED2-D0F5-41CC-8AC7-D182D6933399Q33922193-A9F75E71-B760-4C9E-96C3-CE1D271E3950Q34316845-316F9BE8-05E0-4FD2-9ABD-EA721E44EFFFQ34500602-EFCD9171-EEE6-4750-82AB-2D58B151E66EQ34737158-ABA8EA48-9FB0-48DF-AB82-4C070B99458EQ35019735-3F06907B-367E-41F2-B37F-C3DF34E915E1Q35159084-C72A9A71-94AE-4124-AD21-16BF73F40989Q35183133-D1B5F717-0FA7-407F-8C19-916E89292999Q36025964-2F7B4DE4-5D9C-47DF-BB31-E92117AB2D5DQ36106864-57C68553-BCD3-4002-990E-7E3221C5EFB2Q36176588-CB372C5A-41B8-4CCC-9EC1-E0C0F8EE1DDBQ36310718-A1D44C01-6BEA-4F72-9A95-C288F32D4485Q36467960-C8DCFD4A-F6F9-4B0C-AC74-1DC8711287CCQ36500381-458AAB75-2AF2-4F1C-B903-D4A0E7B8D124Q36558688-B7B5AC82-D2A0-4C85-9FB4-3420A23C6AFAQ36623667-DAAE4516-EC4D-4B3F-AEBF-CF4FB6A38C89Q36627160-0F5237EF-F762-4C8A-83A7-3E3880A9BC28Q36965081-EB708DF2-A089-4ED2-A98A-441F886C1839Q37003627-E5E15457-D911-4C22-A2C5-4592D8448C47Q37066730-C326FC76-E702-4BE5-BC9D-70B687C30A43Q37087083-01B5BC88-F3FC-425D-8060-299971B005AFQ37202789-AB06C253-5678-49B5-8ACF-A024E1C215BBQ37226508-61500C85-B908-4DB1-BBBD-691A2A26805FQ37335783-F0F4CFE2-6168-4F80-9547-92C466EFDE01Q37492132-D6CD9CDB-D1F0-4D82-9A8F-F39FD554E4C9Q37533670-1B543393-66C3-4C61-B703-395D8E9BEEF9Q37724213-0B22105E-2A3E-4656-B421-8EE32F70F847
P2860
Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Postoperative neoadjuvant chem ...... tive randomized trial HIT '91.
@en
Postoperative neoadjuvant chem ...... tive randomized trial HIT '91.
@nl
type
label
Postoperative neoadjuvant chem ...... tive randomized trial HIT '91.
@en
Postoperative neoadjuvant chem ...... tive randomized trial HIT '91.
@nl
prefLabel
Postoperative neoadjuvant chem ...... tive randomized trial HIT '91.
@en
Postoperative neoadjuvant chem ...... tive randomized trial HIT '91.
@nl
P2093
P921
P1476
Postoperative neoadjuvant chem ...... tive randomized trial HIT '91.
@en
P2093
Berthold F
Kortmann RD
P304
P356
10.1016/S0360-3016(99)00369-7
P407
P577
2000-01-01T00:00:00Z